138 related articles for article (PubMed ID: 8385523)
21. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
Tofovic SP; Pong AS; Jackson EK
Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
[TBL] [Abstract][Full Text] [Related]
22. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
23. Sodium intake, angiotensin II receptor blockade, and baroreflex function in conscious rats.
Xu L; Brooks VL
Hypertension; 1997 Jan; 29(1 Pt 2):450-7. PubMed ID: 9039141
[TBL] [Abstract][Full Text] [Related]
24. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
[TBL] [Abstract][Full Text] [Related]
25. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
26. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783
[TBL] [Abstract][Full Text] [Related]
27. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
Toney GM; Porter JP
Brain Res; 1993 Feb; 603(1):57-63. PubMed ID: 8453478
[TBL] [Abstract][Full Text] [Related]
28. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
29. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes.
Kramár EA; Harding JW; Wright JW
Regul Pept; 1997 Jan; 68(2):131-8. PubMed ID: 9110385
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
[TBL] [Abstract][Full Text] [Related]
32. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
[TBL] [Abstract][Full Text] [Related]
33. Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
Siragy HM; El-Kersh MA; De Gasparo M; Webb RL; Carey RM
J Hypertens; 2002 Jun; 20(6):1157-63. PubMed ID: 12023686
[TBL] [Abstract][Full Text] [Related]
34. Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors.
Gigante B; Rubattu S; Russo R; Porcellini A; Enea I; De Paolis P; Savoia C; Natale A; Piras O; Volpe M
Hypertension; 1997 Sep; 30(3 Pt 2):563-8. PubMed ID: 9322982
[TBL] [Abstract][Full Text] [Related]
35. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
Hogarty DC; Tran DN; Phillips MI
Brain Res; 1994 Feb; 637(1-2):126-32. PubMed ID: 8180789
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development.
Tufro-McReddie A; Johns DW; Geary KM; Dagli H; Everett AD; Chevalier RL; Carey RM; Gomez RA
Am J Physiol; 1994 Jun; 266(6 Pt 2):F911-8. PubMed ID: 8023970
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
38. Regulation of vascular angiotensin release.
Kato H; Iwai N; Inui H; Kimoto K; Uchiyama Y; Inagami T
Hypertension; 1993 Apr; 21(4):446-54. PubMed ID: 8458646
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats.
Näveri L; Strömberg C; Saavedra JM
Regul Pept; 1994 Jun; 52(1):21-9. PubMed ID: 7972928
[TBL] [Abstract][Full Text] [Related]
40. Blockade of central angiotensin II type 1 and type 2 receptors suppresses adrenalectomy-induced NaCl intake in rats.
Galaverna O; Polidori C; Sakai RR; Liénard F; Chow SY; Fluharty SJ
Regul Pept; 1996 Oct; 66(1-2):47-50. PubMed ID: 8899892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
